O-GENESIS Graft Delivery System and New Hydrated, Ready-to-Use AlloQuent Structural Allograft Q-PACK Is Launched by Orthofix

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

October 7, 2020

O-GENESIS Graft Delivery System has been launched during the North American Spine Society (NASS) 2020 virtual annual meeting. The news was announced today by Orthofix.

O-GENESIS Graft Delivery System (a complete bone graft delivery system) is designed to deliver allograft, autograft or synthetic bone graft to orthopedic surgical sites. The company is also introducing the AlloQuent Structural Allograft Q-Pack®, a hydrated, ready-to-use form of cervical and lumbar spacers for allograft procedures.

“Orthofix is committed to continuous technology innovation and expanding solutions to improve operating room efficiencies,” said Kevin Kenny, Global President of Orthofix Spine. “The unique design of the O-GENESIS Graft Delivery System enables one-handed delivery of bone graft material in a precise and controlled manner to aid surgeons with the targeted placement of biologics during orthopedic surgeries. Additionally, we are pleased to offer the new AlloQuent Structural Allograft in Q-Pack that allows for immediate use with no downtime for rehydrating. Both of these demonstrate our commitment to providing surgeons with easy-to-use solutions to meet the needs of their patients.”

The O-GENESIS Graft Delivery System works hand-in-hand with our flagship biologic solution, the Trinity ELITE Allograft with viable cells, processed exclusively for Orthofix by MTF Biologics. Designed with ergonomics in mind, the system enables single-handed delivery and features two streamlined loading options to accommodate a versatile choice of other bone graft materials, such as fiberFUSE Demineralized Bone Matrix.*

The AlloQuent Structural Allografts are precision-machined cervical and lumbar spacers. Orthofix has partnered with MTF Biologics to launch AlloQuent in the new Q-Pack Technology − a zero rehydration technology designed to help eliminate preparation time while preserving the mechanical properties of the allograft. AlloQuent structural allografts offer procedure-specific spacers with surgical efficiency in ready-to-use packaging.

*Data on file with Orthofix Medical.

 

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.